Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
CFOs On the Move: Week Ending March 24
Ally Financial, NFL, Papa Johns, Overair, LastPass, Curbio, Hinge Health, Momnt, Sealed Air, Infobip
By
Lauren Muskett
| March 24, 2023
Read More
Resources
Reports
Reports
2023
2022
Featured
People
CFOs On the Move: Week Ending March 24
Ally Financial, NFL, Papa Johns, Overair, LastPass, Curbio, Hinge Health, Momnt, Sealed Air, Infobip
By
Lauren Muskett
| March 24, 2023
Read More
Sign Up
Menu
Reports
2023
2022
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
Sign Up
Sponsored by
Biosimilar
Risk & Compliance
How to Rein In the Soaring Costs of Specialty Drugs
The 420-employer National Business Group on Health recommends public-policy changes relating to the proliferating category of specialty drugs.
By
David McCann
| January 30, 2017
Read More
